Shanghai RAAS Blood Products Co., Ltd.

¥4.94As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002252Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (13.30%)
Div yield 0.98%
ROE 3.34%
Biotechnology
Beta (5Y) 0.32
PE TTM 29.91
TSR TTM (25.10%)
Mkt cap ¥32.57B
ROIC 2.41%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.40
29.47%
26.33%
Hold 3|1|8|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.07
0.08
0.08
0.08
22.06%
20.10%
21.11%
23.00%
Revenue¥B
3.096
3.101
3.113
3.300
14.26%
8.34%
6.86%
10.37%
Peers (US$4.882B)
Cap (US$)
PE
4.719B
—
4.470B
9.667x
Capital
TTM
5Y
10Y
Leveragex
0.622
(1.108)
(1.016)
EBIT/Intx
12.25
0.116
0.149
Own earn%
14.34
(51.22)
(54.46)
Sh yield%
28.81
10.49
17.54
Owners
Insiders/Inst%
12.94
70.21
Short interest%
0.89
SBC / revenue%
5.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
10–18
$1 testx
—
Incr. ROIC%
7